Kiromic Biopharma, Inc. Stock Split Ratio
Kiromic Biopharma, Inc. had Stock Split Ratio of 3000.00% as of 2023-03-10, per its 10-K filed 2024-03-19.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-03-19
- 2023-03-10: Stockholders' Equity Note, Stock Split, Conversion Ratio 3000.00%.
- 2020-06-17: Stockholders' Equity Note, Stock Split, Conversion Ratio 349.40%.
- 2019-12-17: Stockholders' Equity Note, Stock Split, Conversion Ratio 1000.00%.
- 2019-12-16: Stockholders' Equity Note, Stock Split, Conversion Ratio 1000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2023-03-10 | 3000.00% 10-K · filed 2024-03-19 |
| 2020-06-17 | 349.40% 10-K · filed 2022-04-08 |
| 2019-12-17 | 1000.00% 10-K · filed 2021-03-31 |
| 2019-12-16 | 1000.00% 10-K · filed 2021-03-31 |